The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model
- PMID: 20488534
- PMCID: PMC2913156
- DOI: 10.1016/j.biomaterials.2010.04.011
The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model
Abstract
While the infection rate of orthopedic implants is low, the required treatment, which can involve six weeks of antibiotic therapy and two additional surgical operations, is life threatening and expensive, and thus motivates the development of a one-stage re-implantation procedure. Polyelectrolyte multilayers incorporating gentamicin were fabricated using the layer-by-layer deposition process for use as a device coating to address an existing bone infection in a direct implant exchange operation. The films eluted about 70% of their payload in vitro during the first three days and subsequently continued to release drug for more than four additional weeks, reaching a total average release of over 550 microg/cm(2). The coatings were demonstrated to be bactericidal against Staphylococcus aureus, and degradation products were generally nontoxic towards MC3T3-E1 murine preosteoblasts. Film-coated titanium implants were compared to uncoated implants in an in vivo S. aureus bone infection model. After a direct exchange procedure, the antimicrobial-coated devices yielded bone homogenates with a significantly lower degree of infection than uncoated devices at both day four (p < 0.004) and day seven (p < 0.03). This study has demonstrated that a self-assembled ultrathin film coating is capable of effectively treating an experimental bone infection in vivo and lays the foundation for development of a multi-therapeutic film for optimized, synergistic treatment of pain, infection, and osteomyelitis.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures








Similar articles
-
Vitamin E Phosphate Coating Stimulates Bone Deposition in Implant-related Infections in a Rat Model.Clin Orthop Relat Res. 2018 Jun;476(6):1324-1338. doi: 10.1097/01.blo.0000534692.41467.02. Clin Orthop Relat Res. 2018. PMID: 29771856 Free PMC article.
-
[Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits].Chirurgie. 1998 Dec;123(6):572-9. doi: 10.1016/s0001-4001(99)80006-3. Chirurgie. 1998. PMID: 9922597 French.
-
Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats.Biomaterials. 2016 Sep;101:156-64. doi: 10.1016/j.biomaterials.2016.05.039. Epub 2016 Jun 2. Biomaterials. 2016. PMID: 27294535
-
Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review.Injury. 2006 May;37 Suppl 2:S105-12. doi: 10.1016/j.injury.2006.04.016. Injury. 2006. PMID: 16651063 Review.
-
Is coating of titanium implants effective at preventing Staphylococcus aureus infections? A meta-analysis of animal model studies.Int Orthop. 2021 Apr;45(4):821-835. doi: 10.1007/s00264-020-04660-4. Epub 2020 Aug 6. Int Orthop. 2021. PMID: 32761434
Cited by
-
Multi-Layered Hydrogels for Biomedical Applications.Front Chem. 2018 Sep 25;6:439. doi: 10.3389/fchem.2018.00439. eCollection 2018. Front Chem. 2018. PMID: 30320070 Free PMC article. Review.
-
Therapeutics and delivery vehicles for local treatment of osteomyelitis.J Orthop Res. 2020 Oct;38(10):2091-2103. doi: 10.1002/jor.24689. Epub 2020 Apr 21. J Orthop Res. 2020. PMID: 32285973 Free PMC article. Review.
-
Multifunctional Scaffolds and Synergistic Strategies in Tissue Engineering and Regenerative Medicine.Pharmaceutics. 2021 May 26;13(6):792. doi: 10.3390/pharmaceutics13060792. Pharmaceutics. 2021. PMID: 34073311 Free PMC article. Review.
-
Antibiotics- and Heavy Metals-Based Titanium Alloy Surface Modifications for Local Prosthetic Joint Infections.Antibiotics (Basel). 2021 Oct 19;10(10):1270. doi: 10.3390/antibiotics10101270. Antibiotics (Basel). 2021. PMID: 34680850 Free PMC article. Review.
-
Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.Crit Rev Ther Drug Carrier Syst. 2015;32(1):1-59. doi: 10.1615/critrevtherdrugcarriersyst.2014010920. Crit Rev Ther Drug Carrier Syst. 2015. PMID: 25746204 Free PMC article. Review.
References
-
- Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369–379. - PubMed
-
- Soundrapandian C, Datta S, Sa B. Drug-eluting implants for osteomyelitis. Crit Rev Ther Drug. 2007;24(6):493–545. - PubMed
-
- Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis. 2001;32(3):419–430. - PubMed
-
- Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemoth. 2001;48:5–16. - PubMed
-
- Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement - Current concepts. Clin Orthop Relat R. 1984;(190):96–108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical